---

Revenue	--
Net Income	-$11,809,000.00
Total Assets	$83,739,000.00
Total Liabilities	$$3,157,000.00
Stockholders' Equity	($46,174,000.00)

COMPANY NAME	FORM TYPE	DATE RECEIVED	VIEW
Aardvark Therapeutics, Inc.	S-1	2025-01-23 00:00:00	Link
Aardvark Therapeutics, Inc.	S-1	2025-01-23 00:00:00	Link
Aardvark Therapeutics, Inc.	S-1/A	2025-02-06 00:00:00	Link
Aardvark Therapeutics, Inc.	424B4	2025-02-13 00:00:00	Link